In the Sweet Spot · · Cooper Companies (COO) · Healthcare

Cooper Companies: a strategic decision and a quality name in the sweet spot meet on the same day

Cooper Companies reported fiscal Q3 results and closed its CooperSurgical strategic review this week, while its quality and projected return sit squarely in Manifest's sweet spot.

Cooper Companies (COO) was Manifest Investing's In the Sweet Spot daily stock pick for September 10, 2026. At the time of the pick, Cooper Companies carried a quality percentile of 85 and a projected annual return (PAR) of 15.7% against a MIPAR of 9.4%, placing it inside the sweet spot of 14.4% to 19.4%.

Key metrics at the time of the pick

Quality percentile
85
Projected annual return (PAR)
15.7%
MIPAR (median PAR of coverage)
9.4%
PROVE
12.1%
Core score (of 300)
248
Financial strength (of 100)
72
EPS stability (of 100)
90.7
Sales growth forecast
7.9%
P/E ratio
19.3
Price at pick
$63.48
52-week low
$58.89
52-week high
$89.83
Above 52-week low
7.8%
Below 52-week high
29.3%
Dividend yield
0.0%
Projected yield
0.0%
In the sweet spot
Yes
Triple play
Yes

Cooper Companies (NASDAQ: COO) gives us two reasons to look closely today rather than just one. The company reported fiscal third-quarter results on September 9, and in a separate release the same day, its board announced it has completed its strategic review of CooperSurgical, concluding to retain the business while expanding its share repurchase authorization. That’s a real decision point resolving an overhang that had been hanging over the stock, and it lands the same week the market gets a fresh earnings print to react to.

The way we see it, the Manifest signals frame this well. Cooper’s quality percentile sits at 85.3, a ranking derived from financial strength, EPS stability, relative sales growth, and relative profitability measured against the rest of our database, comfortably in “good to excellent” territory. Its projected annual return (PAR), our five-year total-return forecast built from growth, margin, and valuation assumptions, is 15.7%. With MIPAR (the median PAR across all stocks we follow) at 9.4%, the sweet spot we define as MIPAR + 5 to +10 percentage points runs from roughly 14.4% to 19.4%, and Cooper’s PAR sits inside that band, not just brushing an edge.

Layer on the other quality components: a core score of 248 (the sum of quality percentile, financial strength, and EPS stability, each on its own 0-100 scale, for a combined range of 0-300, with 225-plus marking a candidate for “core holding” consideration) and EPS predictability of 90.7 out of 100, among the more consistent earnings track records we track. Financial strength registers at 71.6 out of 100, solid without being fortress-grade. Cooper is also flagged in our analyst file as a Triple Play: an elevated PAR alongside a current P/E below its projected P/E and a current net margin below its projected margin, George Nicholson’s framework for a depressed price paired with room for both multiple expansion and margin improvement.

The price action adds a timing angle. At $63.48, the stock trades 29.3% below its 52-week high of $89.83 and sits only 7.8% above its 52-week low of $58.89.

Our AI review of Cooper’s recent earnings calls (covering Q4 2025 through Q2 2026, so it predates today’s Q3 release) found a mixed but improving picture. On the positive side, the reorganization completed in fiscal Q4 2025 has driven genuine operating leverage, consecutive quarters of essentially flat operating expenses, and free cash flow that management has raised its full-year outlook for twice this fiscal year. MiSight, the company’s myopia-control lens line, has posted sustained strong growth. The clearer caution flag is Asia-Pacific, where organic growth has worsened over consecutive quarters and management’s recovery timeline has slipped more than once; that’s a thread worth watching in whatever commentary accompanies the newly reported quarter.

For context on external expectations: the Wall Street consensus 12-month price target is $69.67 per our data aggregator, a different time horizon than our own five-year PAR framework and not a figure we’d treat as confirming or aligned with it. Cooper’s next scheduled earnings date is December 3, 2026.

None of this is a recommendation to buy, sell, or hold. It’s a snapshot of how our methodology reads a company on a day when its business and its stock price both have something happening, and a starting point for your own research into whether the Asia-Pacific trend and the resolved CooperSurgical question change the picture as more information arrives.

Sources

About In the Sweet Spot

Manifest Investing's daily stock pick: one high-quality company whose projected annual return (PAR) sits in the sweet spot above the market median (MIPAR). Each pick pairs Manifest Investing's quality percentile with its projected annual return (PAR); the sweet spot runs from MIPAR + 5 to MIPAR + 10 percentage points. Browse every pick in the archive.

In the Sweet Spot is educational and is not investment advice or a recommendation to buy or sell any security. Figures reflect Manifest Investing's methodology as of the pick date.